Cost-Effectiveness of DPYD Genotyping Prior to Capecitabine Administration for Metastatic Breast Cancer
Translational and Real-World Evidence of Trastuzumab Biosimilar CT-P6 Plus Pertuzumab in Neoadjuvant HER2-Positive Early Breast Cancer
Assessing the Accuracy of Inflammatory Breast Cancer Self-Reported Diagnoses through the Metastatic Breast Cancer Project from the Count Me In Initiative Database
Using the Cancer Aging and Research Group- Breast Cancer (CARG-BC) predictive model in older adults (OA) with early breast cancer: an external validation study
Whole transcriptome analysis reveal MammaPrint and BluePrint-associated gene expression patterns with early lymph node metastasis in early-stage breast cancer
Impact of lymph node status on the prognosis of female breast cancer patients who underwent immediate reconstruction after total mastectomy: A multi-institutional retrospective cohort study
Exercise decreases Neuregulin-1 concentrations in HER2+ breast cancer patients
Assessing Endocrine Resistance: Monitoring Circulating ESR1 mutations in Irosustat-Treated ER positive Breast Cancer
The impact of adjuvant chemotherapy on overall survival in premenopausal (age≤50 years) hormone and node positive breast cancer patients with an Oncotype Dx score of 25 or less. A NCDB analysis
Survival Impact of Adjuvant Capecitabine In Triple-Negative Breast Cancer Patients with Residual Disease: A Real-World Study
Learn more about Breast Cancer Research and Treatment